United States · FDA National Drug Code directory
Methylprednisolone Sodium Succinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82094-405_94c8ce6b-7622-4d1f-8b54-0ce959752ae5
- Product NDC
- 82094-405
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Methylprednisolone
- Labeler
- Tianjin Kingyork Pharmaceuticals Co., Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210420
- Source listing expiry
- 20261231
Source-listed ingredients
- METHYLPREDNISOLONE SODIUM SUCCINATE — 2 g/30.6mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (82094-405-50) / 30.6 mL in 1 VIAL (82094-405-01) · 82094-405-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →